pidemiology and human intervention trials consistently show inverse associations between dietary fish or fish oil intake and mortality from heart disease. [1] [2] [3] [4] [5] Because of the importance of ischemic coronary artery disease in myocardial infarction, sudden arrhythmic death, and heart failure, research has largely focused on the influence of dietary fats on blood pressure, plasma lipids, atherosclerosis, and thrombosis. 6 -8 Animal studies demonstrate that dietary fats not only modulate platelet and vascular function but also determine the fatty acid composition of myocardial cell membranes. Fish oils are rich sources of the long-chain 3 (n-3) polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Eating fish oil leads to high incorporation of DHA into myocardial membrane phospholipid. 9 -14 Hearts with high DHA content have very low in vivo and in vitro vulnerability to arrhythmia, which is reflected in a low incidence of ventricular fibrillation induced by ischemia, reperfusion, programmed electrical stimulation, or other stimuli. 10 -14 This cannot be attributed to reduced coronary atherosclerosis. 15 Human intervention trials in postinfarction patients demonstrate reduced mortality with regular intake of fish or fish oil, without changes in blood pressure, blood lipids, or new cardiac events. 2, 5 The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Trial, 5 with Ͼ11 000 postinfarction subjects, found that fish oil intake reduced the risk of both sudden and nonsudden death. These reports support the animal data that indicate that fish oil may prevent fatal arrhythmias, and they raise the possibility that further direct effects on heart function may contribute to the cardioprotective effects of n-3 fatty acids. In support of this premise, fish oil feeding increases left ventricular end-diastolic volume and ejection fraction in nonhuman primates and reduces rate pressure product, which may be indicative of low myocardial oxygen consumption (MVO 2 ). 16 We tested the hypothesis that n-3 PUFA incorporation into myocardial membranes has direct effects on heart function, particularly after ischemia, additional to previously reported effects on arrhythmia, thrombosis, and vascular function. We used the erythrocyte-perfused isolated working heart, which provides optimal oxygen delivery and permits assessment of hemodynamic function and metabolism under controlled physiologically relevant conditions. 10,17
Methods

Animals and Diets
Four-month-old male Wistar rats (University of Adelaide, Adelaide, Australia) were fed a fish oil (n-3 PUFA)-supplemented diet, a saturated fat (SAT)-supplemented diet, or a reference diet (REF) rich in n-6 PUFA for 16 weeks (nϭ55 per diet). The REF diet was commercially available, unrefined rat pellets (Milling Industries). The SAT and n-3 PUFA diets were prepared as previously reported 10 by adding sheep peri-renal fat or fish oil to the dry mix components of the unrefined pellets. The fatty acid profile of each diet was published previously. 10 In brief, the n-3 PUFA diet contained 25% saturated fatty acids and 45% PUFA (39% n-3 PUFA as EPA [20:5] and DHA [22:6] ), the SAT diet contained 55% saturated fat and 10% PUFA (7% n-6 PUFA), and the REF diet contained 29% saturated fat and 46% PUFA (34% n-6 PUFA). All diets were consumed iso-energetically, delivering a similar total fat intake to all groups. 10 Experiments were conducted according to the National Health and Medical Research Council Australia Guidelines for the Use of Experimental Animals.
Perfusion Protocol
At least 1 rat was used from each dietary group each experimental day, and was fasted overnight. The experimenter was blind to the diet of each rat. Animals were killed by cervical dislocation, and hearts were removed and prepared for working heart perfusion with porcine erythrocyte buffer (40% hematocrit). 17 Briefly, after 10-minute equilibration in Langendorff mode, hearts were switched to working heart mode (preload, 10 mm Hg; afterload, 75 mm Hg; coronary perfusion pressure, 75 mm Hg; paced heart rate, 300 bpm). Arterial and venous blood gas partial pressures and pH were measured every 5 minutes. MVO 2 was derived from arteriovenous oxygen differences per unit coronary flow, and external work was derived from cardiac output (CO) and developed pressure. 17 In separate experiments, we performed the following: (1) preload was changed over the range 5 to 20 mm Hg by altering ventricular filling pressure. (2) Global ischemia was induced by lowering the coronary pressure to 35 mm Hg for 15 minutes while maintaining afterload at 75 mm Hg and pacing throughout. 23 Reperfusion was initiated by restoring coronary perfusion pressure to 75 mm Hg. 
Statistical Analysis
CO, external work, coronary flow, oxygen extraction, MVO 2 , and metabolites were expressed per gram ventricle dry weight. 17 Results were expressed as meanϮSD. The effect of diet was tested by 1-way ANOVA with Scheffe's post-hoc F test for multiple comparisons of individual means. Effects of ischemia/reperfusion and altered preload were tested by repeated-measures ANOVA. The incidence of ventricular fibrillation in reperfusion was compared using the 2 test. Values in text sharing the same symbol were not significantly different from other dietary groups. The level of significance was considered at PϽ0.05. 
Results
Normoxic Function
Frank-Starling Relationship
The maximum CO (REF, 210Ϯ7; SAT, 201Ϯ3; n-3 PUFA, 272Ϯ18 mL · min Ϫ1 · g Ϫ1 ) was significantly higher in n-3 PUFA hearts. In the REF and SAT hearts, CO was not The percent oxygen extraction increased with preload, but in the n-3 PUFA hearts, this was only seen at the highest preload (max extraction: SAT, 57Ϯ4%; REF, 39Ϯ1%; n-3 PUFA, 40Ϯ2%). MVO 2 increased with preload in all groups, especially at the higher filling pressures ( Figure 3B ) and was significantly greater in SAT and less in n-3 PUFA at all preloads. The efficiency of oxygen conversion into external work increased with preload as external work increased but declined at the high filling pressures as external work stabilized or declined ( Figure 3C ). Efficiency was significantly higher in n-3 PUFA and lower in SAT hearts at all preloads. Lactate washout into the coronary perfusate increased with preload and was significantly higher in SAT and lower in n-3 PUFA hearts (at 20 mm Hg preload: REF, 230Ϯ10; SAT, *295Ϯ5; n-3 PUFA, †125Ϯ12 mol · min Ϫ1 · g Ϫ1 , nϭ10).
Ventricular Function and MVO 2 in Ischemia and Reperfusion
Coronary flow decreased during ischemia ( Figure 4A ), barely exceeded by CO ( Figure 4B ). After reperfusion, CO returned to 83% of preischemic output in n-3 PUFA, 73% in REF, and 62% in SAT hearts ( Figure 4B ). Myocardial external work decreased during ischemia in all groups ( Figure 5A ), and recovery of external work after reperfusion was lowest in SAT and highest in n-3 PUFA hearts. Despite reduced work, MVO 2 was not diminished in reperfusion. Reperfused SAT hearts exhibited the highest, whereas n-3 PUFA hearts had the lowest MVO 2 ( Figure 5B ). This resulted in lower energy utilization efficiency in SAT hearts (ratio of work output energy/energy input from MVO 2 ), whereas n-3 PUFA hearts had significantly higher postischemic energy efficiency than did n-6 PUFA-rich REF hearts (Figure 5C 
Basal MVO 2
Hearts arrested in diastole by 30 mmol/L KCl infusion after reperfusion (nϭ5 per diet) or time-matched control perfusion (nϭ5 per diet) had very low MVO 2 , representing noncontractile (basal) metabolism (Table) . No significant effect of diet or reperfusion was observed after KCl arrest. 
Coronary Flow
Intracellular Calcium Modulation
At a concentration that did not affect CO (data not shown) or external work ( Figure 6A ), ruthenium red reduced MVO 2 in REF and SAT hearts to similar levels as those in n-3 PUFA hearts ( Figure 6B ). Ryanodine had no effect on CO, external work ( Figure 6A ), or MVO 2 ( Figure 6B ) but totally abolished ventricular fibrillation in reperfusion ( Figure 6C ). Ruthenium red had no significant effect on reperfusion arrhythmias (PϾ0.05, 2 ).
Discussion
Dietary fish oil reduced MVO 2 while sustaining cardiac output and external work, revealing an increase in the efficiency of oxygen use under conditions of constant heart rate, preload, and afterload. When hearts were put under stress, such as increased filling pressure or acute myocardial ischemia and reperfusion, this low oxygen demand was associated with enhanced hemodynamic function and reduced production of markers of ischemic damage. Changes in both coronary flow and oxygen extraction contributed to the differences in MVO 2 seen in these hearts. The low coronary flow in n-3 PUFA hearts contrasted to the vasodilator and antihypertensive properties of fish oil 6 and reflected a low oxygen demand. This afforded the n-3 PUFA hearts a high vasodilator reserve, which was revealed by both high workloads and the vasodilator hydralazine. In contrast, the high coronary flow in SAT hearts was not responsive to hydralazine or high workload and represented maximal vasodilation as an adaptive response to increased metabolic requirements, rather than any direct vascular effect. The high MVO 2 and high washout of lactate in SAT hearts under control or high preload conditions and after ischemia further support this supposition. These data highlight further potential adverse cardiovascular effects of dietary saturated fat that are also independent of effects on atherosclerosis and thrombosis.
Effects of Dietary Lipids on
In view of the low MVO 2 and low lactate release in n-3 PUFA hearts, we tested the hypothesis that they would exhibit reduced vulnerability to ischemic stress. Typical responses of venous acidosis and myocardial K ϩ loss were elicited by low-flow global ischemia. Together with the increase in lactate and creatine kinase washout recorded when coronary perfusion pressure and flow were restored in reperfusion, these indicators of acute ischemic stress were greatly attenuated in the n-3 PUFA hearts at high or low workloads. The n-3 PUFA hearts also had better postischemic recovery of hemodynamic and metabolic function, supporting reports of cardioprotective properties in ischemia-reperfusion. 14,18 -22 In reperfusion, disproportionately high MVO 2 , despite a diminished work output, [23] [24] [25] indicates reduced efficiency of oxygen use by the heart. This appears paradoxical, as it contrasts to direct work-related energy requirements. The postischemic efficiency decrease was least evident in n-3 PUFA hearts, and recovery of cardiac work was greater. There was no paradoxical increase in MVO 2 in SAT hearts because of their already high demand, and this was reflected in poor hemodynamic recovery.
These observations extend the range of effects on cardiac function observed in vivo that are associated with dietaryinduced changes in myocardial fatty acid composition. 16 Dietary n-3 PUFA reduced the susceptibility to arrhythmias in the present study, as in other studies. 10 -15 The reduced loss of K ϩ during ischemia may be indicative of effects on ion channels or exchange mechanisms that lead to changes in K ϩ conductance 26 and altered arrhythmic potential. 27 Alternatively, the lower MVO 2 in n-3 PUFA hearts suggested a metabolic reserve, which may contribute to the reduced arrhythmia vulnerability by ensuring energy for maintenance of transmembrane potentials.
Underlying changes in mitochondrial metabolism may contribute to the high oxygen energy utilization efficiency of n-3 PUFA hearts. Reduced rates of mitochondrial respiration are seen in hearts from fish oil-fed rats. 28, 30 Paradoxical increases in MVO 2 during reperfusion may in turn be driven by increased energy requirements to regulate intracellular Ca 2ϩ , which is raised during ischemia. [27] [28] [29] [30] Spontaneous Ca 2ϩ release from sarcoplasmic reticulum and impaired contractility after ischemic injury 29 suggest the ability of sarcoplasmic reticulum to deal with elevated intracellular Ca 2ϩ may also be impaired.
There is direct evidence of elevated intracellular (mitochondrial) Ca 2ϩ in hearts fed saturated fat or REF diets, whereas n-3 PUFA are associated with less activation of Ca 2ϩ -dependent pyruvate dehydrogenase at rest and after stimulation by catecholamines. 30 Lower oxygen consumption by mitochondria isolated from n-3 PUFA hearts, most notably during uncoupled respiration, suggests that augmented n-3 PUFA content in inner mitochondrial membranes may minimize thermodynamic inefficiency because of high rates of proton motive force and proton leak that may underlie futile consumption of excess oxygen after ischemia-reperfusion. 30 State III respiration may also be influenced by n-3 PUFA. 21 The findings of the present study-in which excess MVO 2 was abolished by ruthenium red (blocks mitochondrial uniporter Ca 2ϩ uptake) but not by ryanodine (blocks sarcoplasmic reticulum Ca 2ϩ release), although ryanodine but not ruthenium red abolished postischemic cardiac arrhythmiaspromote the hypothesis that n-3 PUFA prevent intracellular Ca 2ϩ overload. The fatty acid composition of myocardial membrane phospholipid is sensitive to the type of fatty acids consumed in the diet. 9 -14,18 -20,30 -32 Although fish oils often contain mainly EPA, the myocardium, including mitochondrial membrane, accumulates DHA as the principal n-3 PUFA, even after feeding purified EPA. 13 We previously reported the effects of the very diets used in the present study, 10 demonstrating high incorporation of DHA with fish oil feeding. Membrane fatty acid modulation may modify a wide variety of intracellular and membrane events, such as ion flux, respiratory electron transport, carrier-mediated transport, membrane-bound enzyme activity, receptor function, intracellular lipid-based second messengers, and eicosanoid synthesis. 25, 34 Thus, membrane modification of phospholipid properties may impact on many lipid-protein interactions, membrane protein function, and membrane-dependent signaling and metabolism. It is therefore not surprising that dietary lipid-induced modulation of Ca 2ϩ handling 30 -33 via altered cardiac membrane composition may drive both excessive oxygen use and arrhythmia vulnerability.
Diet-induced augmentation of cardiac membrane n-3 PUFA improved ventricular function by reducing the oxygen required to produce any given work output compared with either saturated fat or n-6 PUFA. This was particularly evident at high workloads and was not attributable to altered vascular function. Increased n-3 PUFA incorporation made the myocardium less susceptible to ischemic injury and aided postischemic recovery. These findings provide further support for epidemiological and intervention studies that show associations between n-3 PUFA intake and low incidence of death from coronary heart disease, even after myocardial infarction. [1] [2] [3] [4] [5] The results suggest direct cardioprotective effects of fish oil, beyond the acknowledged antiatherogenic and antithrombotic actions.
